Beam Therapeutics Inc (BEAM)

Oct 14, 2025

What the charts say about Beam Therapeutics Inc. todayMarket Sentiment Report & Real-Time Buy Signal Notifications - newser.com

Oct 14, 2025

Oct 14, 2025

Why Beam Therapeutics Inc. stock is favored by pension funds2025 Market WrapUp & Low Drawdown Investment Ideas - newser.com

Oct 14, 2025

Oct 14, 2025

What analyst consensus says on Beam Therapeutics Inc. stockChart Signals & Free Accurate Trade Setup Notifications - newser.com

Oct 14, 2025

Oct 14, 2025

Should you wait for a breakout in Beam Therapeutics Inc.Earnings Overview Report & Growth Focused Entry Point Reports - newser.com

Oct 14, 2025

Oct 13, 2025

Sickle Cell Disease Pipeline Insights Report 2025: DelveInsight Highlights Cutting-Edge Treatments and Clinical Progress - The Globe and Mail

Oct 13, 2025

Oct 13, 2025

Technical analysis overview for Beam Therapeutics Inc. stockM&A Rumor & High Conviction Trade Alerts - newser.com

Oct 13, 2025

Oct 13, 2025

Visualizing Beam Therapeutics Inc. stock with heatmapsJuly 2025 Review & Technical Buy Zone Confirmation - newser.com

Oct 13, 2025

Oct 12, 2025

Beam Therapeutics Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 12, 2025

Oct 11, 2025

Beam Therapeutics (BEAM): Assessing Valuation After Fresh Buy Ratings, Clinical Updates, and Institutional Moves - Yahoo Finance

Oct 11, 2025

Oct 11, 2025

Jim Cramer on Beam Therapeutics: “That’s the Speculative Bottom There” - MSN

Oct 11, 2025

Oct 11, 2025

Beam Therapeutics (NASDAQ:BEAM) Earns "Buy" Rating from HC Wainwright - MarketBeat

Oct 11, 2025

Oct 10, 2025

Beam Therapeutics (NASDAQ:BEAM) Coverage Initiated by Analysts at Jefferies Financial Group - MarketBeat

Oct 10, 2025

Oct 10, 2025

Does Beam Therapeutics Inc. qualify in momentum factor screeningJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com

Oct 10, 2025

Oct 10, 2025

Bristol Myers Squibb buys Cambridge biotech for $1.5B - The Business Journals

Oct 10, 2025

Oct 10, 2025

HC Wainwright & Co. Reiterates Beam Therapeutics (BEAM) Buy Recommendation - Nasdaq

Oct 10, 2025

Oct 10, 2025

HC Wainwright & Co. Reiterates Buy Rating for BEAM at $80 Target - GuruFocus

Oct 10, 2025

Oct 09, 2025

Beam Therapeutics (NASDAQ:BEAM) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 09, 2025

Beam Therapeutics Stock Soars 7.44%, Hits Intraday High of $27.55 - Markets Mojo

Oct 09, 2025

Oct 09, 2025

Jefferies initiates Beam Therapeutics stock with Buy rating on upcoming catalysts By Investing.com - Investing.com Canada

Oct 09, 2025

Oct 09, 2025

Jefferies initiates Beam Therapeutics stock with Buy rating on upcoming catalysts - Investing.com Canada

Oct 09, 2025

Oct 09, 2025

Jefferies Initiates Beam Therapeutics with "Buy" Rating, Eyeing Promising Gene-Editing Pipeline and Upcoming Catalysts - FinancialContent

Oct 09, 2025

Oct 09, 2025

Jefferies Initiates Beam Therapeutics at Buy Rating, $41 Price Target - MarketScreener

Oct 09, 2025

Oct 09, 2025

Does Beam Therapeutics Inc. show high probability of reboundEntry Point & Step-by-Step Swing Trade Plans - newser.com

Oct 09, 2025

Oct 09, 2025

SteelPeak Wealth LLC Invests $391,000 in Beam Therapeutics Inc. $BEAM - MarketBeat

Oct 09, 2025

Oct 09, 2025

Sector ETF performance correlation with Beam Therapeutics Inc.Product Launch & Low Risk Investment Opportunities - newser.com

Oct 09, 2025

Oct 09, 2025

Is Beam Therapeutics Inc. stock entering bullish territoryPortfolio Update Summary & Real-Time Volume Analysis - newser.com

Oct 09, 2025

Oct 08, 2025

Why Intellia Therapeutics’ Stock Could Be a Gene‑Editing Goldmine in 2025 – Deep Dive into NTLA’s Prospects - ts2.tech

Oct 08, 2025

Oct 08, 2025

Jim Cramer Sees More Upside For Shopify, Likes CoreWeave's AI Moves - Benzinga

Oct 08, 2025

Oct 08, 2025

What Does Wall Street Think About Beam Therapeutics (BEAM)? - MSN

Oct 08, 2025

Oct 08, 2025

Beam Therapeutics to Participate in Upcoming September 2025 Investor Conferences - FinancialContent

Oct 08, 2025

Oct 06, 2025

Using Ichimoku Cloud for Beam Therapeutics Inc. technicalsQuarterly Profit Summary & Low Risk Entry Point Tips - newser.com

Oct 06, 2025

Oct 03, 2025

Recent Insider Transactions at Beam Therapeutics - TradingView

Oct 03, 2025

Oct 03, 2025

Beam Therapeutics, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 03, 2025

Oct 01, 2025

Beam Therapeutics Shows Rising Price Performance With Jump To 81 RS Rating - MSN

Oct 01, 2025

Sep 29, 2025

Beam Therapeutics Inc Stock Analysis and ForecastGlobal Market Influence & Budget Friendly Capital Growth - earlytimes.in

Sep 29, 2025

Sep 29, 2025

What analysts say about Beam Therapeutics Inc stockRelative Strength Index (RSI) & Master Timing Market Moves - earlytimes.in

Sep 29, 2025

Sep 29, 2025

Is Beam Therapeutics Inc. (BEAM) the Best Emerging Technology Stock to Buy Now? - MSN

Sep 29, 2025

Sep 28, 2025

H.C. Wainwright Maintains Buy on Beam (BEAM), $80 Target on Pipeline Momentum - MSN

Sep 28, 2025

Sep 28, 2025

Is Beam Therapeutics Inc a good long term investmentGrowth vs. Value Investing & Affordable Investment Portfolio - earlytimes.in

Sep 28, 2025